Microdosing psilocybin for mood and thinking
Part of Mental health clinical trials.
This study tests microdoses of psilocybin—the active ingredient in magic mushrooms—to see if they can improve thinking, mood, and quality of life. You'll take a very small amount regularly and track your progress on a smartphone app.
Summary written for real people, not researchers, by Clin2.
Who can take part
- No use of psychedelics ever, or only very limited and distant use (e.g., 7 or fewer times in your life, and none in the last 10 years).
- Able to read, speak, and understand English.
- Willing to provide written consent and stick to the study schedule.
- If you can become pregnant, you must use a reliable form of birth control.
- Must have a smartphone that can run the mindLAMP app.
- No current or past alcohol/substance use disorder, major mental health conditions (like schizophrenia, bipolar, or depression), or serious medical/neurological issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
Hear when a new Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.